Your search returned 8 results.

Results
	1.	[Determination of anti-HIV using an automated ELFA method (enzyme linked immunofluorescent assay)(VIDAS HIV 1/2 new)]. [electronic resource] by Jaqueti, J Búa, M C Preciado, B Producer: 19980105 In: Enfermedades infecciosas y microbiologia clinica vol. 15 Availability: No items available. Save to lists Add to cart (remove)
	2.	Virus-like particles in Urastoma cyprinae, a turbellarian parasite of Mytilus galloprovincialis. [electronic resource] by Crespo-González, C Rodríguez-Domínguez, H Soto-Búa, M Segade, P Iglesias, R Arias-Fernández, C García-Estévez, J M Producer: 20080619 In: Diseases of aquatic organisms vol. 79 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Parasites of swordfish from the Gulf of Guinea. [electronic resource] by Castro-Pampillón, J A Rodríguez-Domínguez, H Soto-Búa, M Mejuto-García, J Arias-Fernández, C García-Estévez, J M Producer: 20020712 In: The Journal of parasitology vol. 88 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	High rate of stem cell mobilization failure after thalidomide and oral cyclophosphamide induction therapy for multiple myeloma. [electronic resource] by Auner, H W Mazzarella, L Cook, L Szydlo, R Saltarelli, F Pavlu, J Bua, M Giles, C Apperley, J F Rahemtulla, A Producer: 20110804 In: Bone marrow transplantation vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse. [electronic resource] by Marin, D Kaeda, J Szydlo, R Saunders, S Fleming, A Howard, J Andreasson, C Bua, M Olavarria, E Rahemtulla, A Dazzi, F Kanfer, E Goldman, J M Apperley, J F Producer: 20050526 In: Leukemia vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Response to donor lymphocyte infusions for chronic myeloid leukemia is dose-dependent: the importance of escalating the cell dose to maximize therapeutic efficacy. [electronic resource] by Simula, M P Marktel, S Fozza, C Kaeda, J Szydlo, R M Nadal, E Bua, M Rahemtulla, A Kanfer, E Marin, D Olavarria, E Goldman, J M Apperley, J F Dazzi, F Producer: 20070604 In: Leukemia vol. 21 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Prognostic factors for patients with chronic myeloid leukaemia in chronic phase treated with imatinib mesylate after failure of interferon alfa. [electronic resource] by Marin, D Marktel, S Bua, M Szydlo, R M Franceschino, A Nathan, I Foot, N Crawley, C Na Nakorn, T Olavarria, E Lennard, A Neylon, A O'Brien, S G Goldman, J M Apperley, J F Producer: 20031106 In: Leukemia vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib. [electronic resource] by Marin, D Gabriel, I H Ahmad, S Foroni, L de Lavallade, H Clark, R O'Brien, S Sergeant, R Hedgley, C Milojkovic, D Khorashad, J S Bua, M Alsuliman, A Khoder, A Stringaris, K Cooper, N Davis, J Goldman, J M Apperley, J F Rezvani, K Producer: 20120330 In: Leukemia vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)